Human Immunoglobulin (pH4) for Intravenous Injection Market Growth Accelerated by Rising Demand for Treatment of Immune Deficiencies

 Human immunoglobulin (pH4) for intravenous injection is derived from human blood plasma which contains antibodies that protect against various infections. It is administered to patients suffering from immune deficiencies who are unable to produce sufficient antibodies to fight diseases. The product finds widespread application in treatment of primary immune deficiencies, immune thrombocytopenic purpura, Guillain-Barré syndrome, and Kawasaki disease among others. It helps supplement the immune system of patients and protects them from various pathogens and infections.

The global Human Immunoglobulin (pH4) for Intravenous Injection Market is estimated to be valued at US$2,055.76 Mn in 2023 and is expected to exhibit a CAGR of 16% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
The rising cases of immune deficiencies due to genetics, immunosuppressive therapies for cancer and organ transplantation has significantly contributed to the growth of this market. The rising demand for immune globulin therapeutics has prompted manufacturers to focus on strategic expansions and new product development. Additionally, increasing research on plasma fractionation and production technologies is also supporting market growth. Advanced technologies help increase plasma collection volumes and improve yields of immunoglobulin products. This enables greater supply of affordable and high quality immune globulin intravenous products globally.

Segment Analysis
The global Human Immunoglobulin (pH4) for Intravenous Injection market is dominated by the 10g/vial sub segment. 10g/vial sub segment holds around 60% of the total market share due to its widespread adoption by healthcare providers for treating mild to moderate cases of primary immunodeficiency disease. The sub segment offers economical treatment option for common variable immunodeficiency (CVID) and other antibody deficiency conditions.

Key Takeaways

The global Human Immunoglobulin (pH4) for Intravenous Injection Market is estimated to be valued at US$ 2,055.76 Mn in 2023 and is expected to exhibit a CAGR of 16% over the forecast period 2023 to 2030.


North America is expected to dominate the global Human Immunoglobulin (pH4) for Intravenous Injection market during the forecast period. High prevalence of antibody deficiency disorders such as CVID and XLA coupled with strong reimbursement policies for immunoglobulin treatments in countries like the US and Canada. Moreover, presence of key market players are fueling the market growth in the region.

Key players operating in the Human Immunoglobulin (pH4) for Intravenous Injection market are Major players operating in the point of care infectious disease diagnostics market include Danaher Corporation, Abbott Laboratories, Alcon Laboratories, Inc., Hoffman-La Roche Ltd., Becton, Dickinson, and Company, Trinity Biotech Plc, AccuBioTech Co., Ltd. and Cardinal Health, Inc. These players are focusing on new product launches and regulatory approvals to expand their market share. For instance, in October 2022, Takeda Pharmaceutical Company received FDA approval for its 10% liquid formulation of subcutaneous immunoglobulin (SCIg).

Comments

Post a Comment

Popular posts from this blog

Neuroendocrine Cancer is the fastest growing segment fueling the growth of Pituitary Cancer Market

Image
The pituitary cancer market comprises of medical treatment options for patients diagnosed with pituitary cancer. Pituitary cancers are rare tumors that start in the pituitary gland which is a pea-sized gland located at the base of the brain.  The global Pituitary Cancer Market is estimated to be valued at US$ 380.7 Mn in 2023 and is expected to exhibit a CAGR of 9.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.    Market key trends: One of the key trends fueling the growth of the pituitary cancer market is rising preference of targeted drug therapy over conventional chemotherapy. Targeted drug therapies mainly include somatostatin analogs and dopamine agonists which directly act on cancer cells and have less side effects compared to chemotherapy. These targeted drugs are effective in controlling symptoms and slowing tumor growth in patients with hormone secreting pituitary adenomas and carcinomas. The targe...
Read more

Enhancing Patient Care and Comfort: The Evolution of Hospital Beds

Image
  Hospital beds play a crucial role in patient care, providing comfort, safety, and functionality for individuals requiring medical attention. Over the years, advancements in technology and design have revolutionized hospital beds, leading to improved patient outcomes and caregiver efficiency. From basic adjustable beds to sophisticated models equipped with cutting-edge features, the evolution of hospital beds has transformed the healthcare landscape. Evolution of Hospital Beds: Historically, hospital beds were simple in design, primarily consisting of a metal frame with adjustable height and manual controls. However, as medical practices advanced and patient needs became more complex, the demand for more versatile and ergonomic hospital beds grew. In recent decades, significant strides have been made in the development of hospital bed technology. Modern hospital beds are designed with a focus on patient comfort, safety, and mobility. Features such as electronic controls, motorize...
Read more

Dry Eye Disease Market is Estimated to Witness High Growth Owing to Rising Awareness About Disease Management

Image
  Dry eye disease, also known as keratoconjunctivitis sicca, is a multifactorial disease of the ocular surface characterized by lack of sufficient moisture and tear film instability. Common symptoms of dry eye include stingy or burning sensation in eyes and blurred vision.   Market Dynamics : The Dry Eye Disease Market is witnessing high growth owing to rising awareness about disease management and increasing number of people experiencing symptoms of dry eyes. According to the report, increasing usage of electronic devices and prolonged screen time is a major driver fueling the demand for dry eye treatments. Additionally, growing geriatric population worldwide who are more prone to dry eyes is also contributing to the market growth. Availability of various treatment options along with new product launches is further expected to boost the market during forecast period.   Increasing Prevalence of Dry Eye Disease is Driving Market Growth   One of the major market drive...
Read more